Silent myocardial ischaemia in the elderly

Area of Science:

• Cardiology
• Geriatric Medicine
• Internal Medicine

Background:

• Coronary artery disease (CAD) is a major cause of mortality and morbidity in the elderly population.
• Silent myocardial ischemia (SMI) is a frequent, often asymptomatic, presentation of CAD in older adults.
• SMI can be present in up to 40% of elderly patients without a prior CAD diagnosis and 50% with known CAD.

Purpose of the Study:

• To highlight the prevalence and diagnostic challenges of silent myocardial ischemia (SMI) in the elderly.
• To review current therapeutic strategies for SMI in this demographic.
• To identify gaps in knowledge regarding the long-term benefits of SMI treatment in older adults.

Main Methods:

• Review of recent studies on silent myocardial ischemia in elderly patients.
• Discussion of diagnostic methods, including ambulatory 24- to 48-hour Holter monitoring.
• Evaluation of anti-ischaemic drug efficacy for SMI management.

Main Results:

• Silent myocardial ischemia is a common finding in elderly patients, even those on antianginal therapy.
• Ambulatory Holter monitoring is essential for diagnosing residual SMI during daily activities.
• Beta-blockers, alone or in combination with nitrates or calcium antagonists, appear to be the most effective treatment for SMI.

Conclusions:

• Silent myocardial ischemia is a significant clinical issue in the elderly population.
• Effective diagnosis and management of SMI are crucial, despite the absence of typical anginal symptoms.
• Further research is needed to establish the long-term clinical benefits of treating SMI in elderly individuals.